BackIbere Pharmaceuticals Overview

Ibere Pharmaceuticals Net Income

Profitability analysis for IBER.

Quarterly Net Income

$1.81M
↑ 4.74% YoY

As of Sep 2022

Annual Net Income (TTM)

$13.41M

Trailing 12 months ending Sep 2022

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin